Skip to main content
Anjali Owens, MD, Cardiology, Philadelphia, PA

AnjaliTOwensMD

Cardiology • Philadelphia, PA

Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation, Interventional Cardiology

Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Owens is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Owens' full profile

Already have an account?

  • Office

    3400 Spruce St
    Philadelphia, PA 19104
    Phone+1 215-314-0343

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2010 - 2011
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2007 - 2010
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2003, B.A.

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2003 - 2024

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical Practice  
    Muthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology

Lectures

  • Genetic Testing in HCM: Where are We Now and Where to Do We Need to Go? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to KnowFebruary 2020
  • Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to KnowFebruary 2020

Press Mentions

  • Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
    Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific SessionsSeptember 27th, 2024
  • U.S. Food and Drug Administration Approves Camzyos™ (Mavacamten) for the Treatment of Adults with Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms
    U.S. Food and Drug Administration Approves Camzyos™ (Mavacamten) for the Treatment of Adults with Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and SymptomsApril 29th, 2022
  • FDA Approves Mavacamten, First Treatment for Obstructive Hypertrophic Cardiomyopathy
    FDA Approves Mavacamten, First Treatment for Obstructive Hypertrophic CardiomyopathyApril 29th, 2022
  • Join now to see all

Dr. Anjali Owens, Dr. Anjali Owens, MD, Dr. A Owens, Dr. Anjali T Owens